Latest Nutrition News


For Many Kids, Picky Eating Isn't Just a Phase, Study Finds

TUESDAY, May 26, 2020 (HealthDay News) -- For parents hoping their "picky" eater will grow out of it, a new study may be unwelcome news. Researchers found that choosy 4-year-olds were still turning their noses up at many foods at age 9 -- suggesting their finicky eating is more of a trait than a phase. The study, which followed over 300 children, found three patterns: The majority were consistently middle-of-the-road when it came to food fussiness -- sometimes shunning unfamiliar cuisine, but remaining relatively open to trying new foods. A sizable minority (29%) consistently ate everything their parents offered up. Then there was the picky 14%. From age 4 to 9, they routinely refused new foods and maintained a limited culinary repertoire. Still, researchers saw bright spots in...

AHA News: A Nutritious Side Dish to Grill This Memorial Day

22 May 2020
FRIDAY, May 22, 2020 (American Heart Association News) -- The coronavirus has put a damper on Memorial Day outings, but you can still kick off barbecue season with healthy grilled fruit kebabs. Skewers filled with pineapple, strawberry, banana and watermelon offer a smart alternative to typical holiday desserts like ice cream and cake. "All fruits are nutritious because they're a source of micronutrients, dietary fibers and polyphenols, the latter of which have antioxidant and anti-inflammatory benefits," said Penny Kris-Etherton, a registered dietitian and professor of nutrition at Pennsylvania State University's Department of Nutritional Sciences. "Many studies have shown that higher fruit intake is associated with better health and a decreased risk of chronic disease-related...

Keto Diet Might Change Your Gut in More Ways Than One

20 May 2020
WEDNESDAY, May 20, 2020 (HealthDay News) -- The now-trendy keto diet is said to turn fat into fuel. But a new, small study says it may also change the vast array of microbes residing in your gut (the microbiome). That could be a good thing, as those changes may ultimately strengthen the immune system by tamping down inflammation, researchers say. The keto diet, which severely restricts carbohydrates and emphasizes fats and protein, has been touted as a way to rein in epilepsy, diabetes and expanding waistlines. Yet despite rising popularity, it remains controversial, and much is unknown about its true impact on health. The new finding follows a two-month study that tracked diet-related shifts in microbiome content among 17 overweight or obese men, with follow-up tests in...

AHA News: Cooking More at Home? Diverse Food Cultures...

20 May 2020
WEDNESDAY, May 20, 2020 (American Heart Association News) -- For many in the United States, dinner means a large portion of meat and two sides, usually a starch and a vegetable. Think steak, potatoes and peas, or chicken, carrots and rice. "That's a very American and northern European idea – a meal which stems from a large amount of meat being available, and also wealth," said Amy Bentley, a professor of food studies at New York University. But trying different dishes from diverse cultures can open up a new menu of heart-healthy food options and go-to meal ideas. And now, with more people making their own meals as they stay home to limit the spread of the coronavirus, what better time than World Day of Cultural Diversity to try something different for dinner? Meat is just an accent on...

Qinlock Approved as Fourth-Line Treatment for GIST

18 May 2020
MONDAY, May 18, 2020 (HealthDay News) -- The U.S. Food and Drug Administration approved Qinlock (ripretinib) tablets as a fourth-line treatment for adults with advanced gastrointestinal stromal tumors (GISTs), the agency announced Friday. The approval follows four other FDA-approved target therapies for GIST, including imatinib in 2002, sunitinib in 2006, regorafenib in 2013, and avapritinib in January. Qinlock is indicated for patients who have received at least three kinase inhibitor therapies, including imatinib. Approval of Qinlock was based on data from an international, multicenter, randomized, double-blind, placebo-controlled clinical trial with 129 patients with advanced GIST who had previously received treatment with other targeted therapies. Patients were randomly assigned...

Theme picker


Copyright © 2018 HealthDay. All rights reserved.